Wednesday, 20 Sep 2023 | Funding Deadline
Applications to this call must aim to accelerate the development of an application for a platform study to evaluate pharmaceutical and/or digital interventions and technologies, individually or in combination, to support sustainable weight loss for people with overweight and obesity (applicants to define and justify specific inclusion criteria, which may include sub-groups with obesity-associated co-morbidities).
Applications to this call must define and justify the specific challenges which will be addressed within the award and how they will ultimately enable a complete application to be made.
The Efficacy and Mechanism Evaluation (EME) Programme is accepting straight-to-Stage 2 applications for this commissioned workstream.
Deadline for proposals: 20 September 2023
Find out more here